SAINT-PRIEST, France--(BUSINESS WIRE)--Regulatory News: Biom’up (Paris:BUP) (the "Company"), specializing in surgical hemostasis, has announced that the U.S. Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results